| Date | Title | Description |
| 26.08.2026 | Solace Announces Appointment of Mike Capone to Board of Directors | Appointment follows Solace's closing of a single-asset continuation vehicle with US$790 million (C$1.1 billion) in commitments, in partnership with majority investor Bridge Growth Partners
Capone brings over 30 years of experience scaling g... |
| 07.05.2026 | MedTech Breakthrough Announces 2026 Award Winners: Celebrating a Decade of Health Technology Innovation | What You Should Know
MedTech Breakthrough has announced the winners of its 10th annual awards program, recognizing excellence in digital health and medical technology across more than 20 countries.
The 2026 awards highlight a decade of evol... |
| 21.04.2026 | Suvoda introduces agentic RTSM, cutting clinical trial start-up timelines by up to 80% | Next-generation, AI-powered Randomization and Trial Supply Management system—designed to get studies to first-patient-in significantly faster
CONSHOHOCKEN, Pa., April 21, 2026 /PRNewswire/ -- Getting a clinical trial from contract to go-liv... |
| 29.01.2026 | uMotif Posts Strong Growth, Earns Market Accolades for eCOA Platform, Demonstrates Continued Clinical Trial Industry Leadership in 2025 | Everest Group gives uMotif highest possible technology rating in eCOA market assessment; Chief Scientific Officer Florence Mowlem PhD leads C-Path publication of industry-wide Event-Driven eDiary best practices in Nature Digital Medicine; f... |
| 12.01.2026 | Suvoda sets new standard for streamlined patient and site experience in clinical trials | CONSHOHOCKEN, Pa., Jan. 12, 2026 /PRNewswire/ -- Suvoda, a clinical trial technology company, took decisive steps in 2025 toward a more connected and streamlined clinical trial experience for both patients and sites. The company's merger wi... |
| 15.12.2025 | uMotif Chief Scientific Officer Leads Publication of Fundamental Work Detailing Industry-Wide Recommendations for Adopting Event-Driven eDiaries in Clinical Trials | On behalf of the Critical Path Institute (C-Path) Florence Mowlem PhD, led this much-needed project, providing 10 best practices for EDeD design and implementation to support clinical trial data capture, along with co-authors from Top 10 ph... |
| 12.12.2025 | Suvoda IRT named a Leader in Everest Group's RTSM PEAK Matrix® | CONSHOHOCKEN, Pa., Dec. 11, 2025 /PRNewswire/ -- Suvoda, a global clinical trial technology company, today announced that its IRT (Interactive Response Technology) software, also known as RTSM (Randomization and Trial Supply Management), ha... |
| 29.10.2025 | Suvoda launches unified patient app to reduce logistical challenges for clinical trial participants | CONSHOHOCKEN, Pa., Oct. 29, 2025 /PRNewswire/ -- Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company specializing in software solutions to address trial complexity in mission-critical,... |
| 25.09.2025 | Suvoda and Greenphire complete brand integration with unified website and social media presence | CONSHOHOCKEN, Pa., Sept. 25, 2025 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company, today announced the completion of its brand integration with Greenphire, unifying both companies under the Suvoda name and brand.
Foll... |
| 24.04.2025 | Suvoda and Greenphire Announce Completion of Merger | CONSHOHOCKEN, Pa. and KING OF PRUSSIA, Pa., April 24, 2025 /PRNewswire/ -- Suvoda, a global clinical trial technology company specializing in randomization and trial supply management, consent, and patient outcomes data collection solutions... |
| 05.03.2025 | Suvoda launches Sofia, a new AI assistant to simplify management of clinical trials | From many clicks to one query, drug supply managers can more quickly access, analyze, and visualize the trial supply data they need.
PHILADELPHIA, March 6, 2025 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that spe... |
| 14.11.2024 | Suvoda Awarded US Patent for its eCOA Software Architecture | Low-code, no-code approach accelerates eCOA questionnaire design and deployment, taking questionnaire creation, licensing, and localization off the critical path
PHILADELPHIA, Nov. 14, 2024 /PRNewswire/ -- Suvoda, a global clinical trial te... |
| 27.06.2024 | Suvoda Expands its Clinical Trial Offering with the Introduction of ePatient | With the focus on improving patient experience and reducing burden on sites
PHILADELPHIA, June 27, 2024 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like onc... |
| 26.06.2024 | Suvoda Expands its Clinical Trial Offering with the Introduction of ePatient | With the focus on improving patient experience and reducing burden on sites
PHILADELPHIA, June 26, 2024 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like onc... |
| 19.03.2024 | Suvoda Introduces eConsent Advancements to Increase Patient Comprehension, Reduce Site Burden, and Improve Overall Experience | Research found 47% of study sites were likely to use an eConsent solution that enhances patient comprehension and engagement
PHILADELPHIA, March 19, 2024 /PRNewswire/ -- Suvoda LLC, a leading global clinical trial technology company special... |
| 08.01.2024 | Suvoda Announces 30% Growth in 2023 Driven by Strong Customer Adoption of New Suvoda Platform and Products | Company maintained industry-leading quality metrics throughout growth surge.
PHILADELPHIA, Jan. 8, 2024 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like onc... |
| 18.10.2022 | IRT Transformation for Greater Supply Efficiency, Upcoming Webinar Hosted by Xtalks | Hear first-hand accounts from clinical trial supply experts with deep expertise in IRT, forecasting and optimization, and clinical trial management.
TORONTO (PRWEB) October 18, 2022
Interactive Response Technology (IRT) systems have been a ... |
| 07.07.2021 | Suvoda Announces the Expansion of its Leadership Team to Support Worldwide Growth
USA - English Deutschland - Deutsch France - Français España - español | |
| 02.07.2021 | PACT held its annual Enterprise Awards IRL this week. Here’s who was honored | For the first time in about a year and a half, the Philadelphia Alliance for Capital and Technologies (PACT) gathered tech and healthcare innovators from across the region for an in-person event to celebrate the org’s annual Enterprise Awar... |
| 25.06.2021 | Acurx Pharmaceuticals LLC : , Inc. announces pricing of $15 Million underwritten Initial public offering of common stock | STATEN ISLAND, N.Y., June 25, 2021 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) (the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infec... |
| 17.03.2021 | Strategies to Automate Dynamic Supply in Complex Oncology Trials, Upcoming Webinar Hosted by Xtalks | With fluctuating patient numbers and dosages, clinical supply managers must be nimble in their approach and prolific in planning out potential strategies.
TORONTO (PRWEB) March 17, 2021
In complex oncology trials, sponsors need flexibility ... |
| 09.02.2021 | Managing Early Phase Oncology Trials and Supply for Efficiency, Upcoming Webinar Hosted by Xtalks | In this panel discussion, participants will hear from industry experts at the intersection of small sample size trials and cutting-edge clinical software on how they can manage through a number of difficult scenarios.
TORONTO (PRWEB) Februa... |
| 09.12.2019 | Clinical Trial Software Suvoda Closes $40 Million In Funding | Clinical trial software company Suvoda announced that it raised $40 million in minority equity investment from LLR Partners
Suvoda LLC — a SaaS provider of clinical trial software — announced it raised $40 million in minority equity investm... |
| 05.12.2019 | Suvoda Receives $40M Investment from LLR Partners | Suvoda LLC, a Conshohocken, Pa.-based SaaS provider of clinical trial software, secured a $40m minority equity investment from Philadelphia-based private equity firm LLR Partners.
The company intends to use the funds for the continued growt... |
| 05.12.2019 | Suvoda Secures $40M Investment from LLR Partners | Suvoda LLC, a SaaS provider of clinical trial software, announced it secured a $40 million minority equity investment from Philadelphia-based private equity firm, LLR Partners. LLR's investment is the first institutional capital invested in... |
| 20.11.2018 | Littlejohn & Co. LLC Closes on $2.84 Billion Private Equity Fund VI | GREENWICH, Conn.--(BUSINESS WIRE)--Littlejohn & Co., LLC, a private investment firm based in Greenwich, CT, today announced the successful final closing of Littlejohn Fund VI, L.P. with $2.84 billion of committed capital, exceeding the ... |
